Although differing in study design (prospective vs. retrospective) and in particular endpoints and sample size, the three studies together consistently identified statistically significant associations between elevated levels of hs-cTnT and increased risk for major adverse cardiac events, including all-cause death, cardiac death, ventricular arrhythmias, and heart failure hospitalization. This evidence concerns the gene TNNT2 and heart failure.